about
The synthetic purine reversine selectively induces cell death of cancer cellsA proline-rich loop mediates specific functions of human sialidase NEU4 in SK-N-BE neuronal differentiation.Complexity in influenza virus targeted drug design: interaction with human sialidases.Properties of recombinant human cytosolic sialidase HsNEU2. The enzyme hydrolyzes monomerically dispersed GM1 ganglioside molecules.Crystal structure of the human cytosolic sialidase Neu2. Evidence for the dynamic nature of substrate recognition.Extracellular sphingosine-1-phosphate: a novel actor in human glioblastoma stem cell survivalMolecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles.Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer CellsInsights into the Binding of Cyclic RGD Peptidomimetics to α5β1 Integrin by using Live-Cell NMR And Computational Studies.Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistanceHSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma.Sialidase NEU4 is involved in glioblastoma stem cell survival.NEU3 sialidase is activated under hypoxia and protects skeletal muscle cells from apoptosis through the activation of the epidermal growth factor receptor signaling pathway and the hypoxia-inducible factor (HIF)-1αThe plasma membrane sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling β1 integrin internalization and recycling.Down regulation of membrane-bound Neu3 constitutes a new potential marker for childhood acute lymphoblastic leukemia and induces apoptosis suppression of neoplastic cells.NEU3 sialidase strictly modulates GM3 levels in skeletal myoblasts C2C12 thus favoring their differentiation and protecting them from apoptosis.Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle.Gangliosides as a potential new class of stem cell markers: the case of GD1a in human bone marrow mesenchymal stem cells.Acidic and neutral sialidase in the erythrocytes of patients with type 2 diabetes: an answer to comments by Richard et al.The plasma membrane-associated sialidase MmNEU3 modifies the ganglioside pattern of adjacent cells supporting its involvement in cell-to-cell interactions.Over-expression of mammalian sialidase NEU3 reduces Newcastle disease virus entry and propagation in COS7 cells.Membrane restructuring following in situ sialidase digestion of gangliosides: Complex model bilayers by synchrotron radiation reflectivity.Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells.Protective role of 17-β-estradiol towards IL-6 leukocyte expression induced by intense training in young female athletes.Prevalence of a characteristic gene profile in high-level rhythmic gymnasts.NEU4L sialidase overexpression promotes β-catenin signaling in neuroblastoma cells, enhancing stem-like malignant cell growth.Glycoglycerolipid analogues inhibit PKC translocation to the plasma membrane and downstream signaling pathways in PMA-treated fibroblasts and human glioblastoma cells, U87MG.Modification of sialidase levels and sialoglycoconjugate pattern during erythroid and erytroleukemic cell differentiationDifferent behavior of ghost-linked acidic and neutral sialidases during human erythrocyte ageingExpression of sialidase Neu2 in leukemic K562 cells induces apoptosis by impairing Bcr-Abl/Src kinases signalingErythrocyte membrane alterations during ageing affect beta-D-glucuronidase and neutral sialidase in elderly healthy subjectsIdentification of lysosomal sialidase NEU1 and plasma membrane sialidase NEU3 in human erythrocytesDexamethasone-Induced Skeletal Muscle Atrophy Increases O-GlcNAcylation in C2C12 Cells
P50
Q28267191-031EA268-DB83-498E-840D-CC83918A781BQ30153509-695D653D-5E0D-4E6B-B538-FE4DC612BBA6Q30386583-93200952-A81D-4664-8915-6E3B948B1D1AQ34276292-7AD2AD4E-58C7-4EC4-9E84-4E39BF533C06Q34361455-A425A5F5-84BD-419C-8E6A-E33FCD166609Q34797919-E1B6492E-CAB5-4F2C-9573-6AFBD1C871CFQ35217621-8578EFB1-79C6-4F14-95A1-C70AF9304537Q35845319-0AD918CC-E026-4E04-997A-D5F254BED2CAQ36272448-60C600D5-9E69-413C-BEDE-1885D78341ACQ38195691-CC97DE5E-376C-4DDD-85BA-8E804E46B38AQ38921685-4DE029B2-E194-4AB8-9109-796148C2927CQ38964051-2633A657-576F-40CF-B95E-7D8DD051487EQ39233050-8E764422-9D34-4543-ABC2-67F754A591C9Q39247356-5C8E8F0E-D632-43AD-859A-89BAA8CBE23AQ39827161-0D80D589-47F1-45A2-9BFE-F2FD0B83F2FEQ39926388-C0C41640-C77F-4F6E-9428-7AD63CE346F4Q40275042-DD837C9D-8DC4-4C8A-A552-5EEDD77D3EF5Q41978112-B7ECDFB9-565B-4CA1-91D9-F2A207A6443BQ44313252-324D1CF5-0CFA-4C35-9CBD-5AAD22FED198Q44768457-D0309301-9BD4-4B0B-A7AA-50DB56A7EA26Q45398153-8E30C75C-AB84-40A5-8E7B-B156F5208EA9Q46432746-7F47456B-A05F-4416-98E9-501F1CB1667BQ48649561-09FCD8AB-EE07-4D22-81E6-7ED8DDA194B9Q51205718-BF3D0559-175F-46D9-829D-EA82C10D85FDQ53092065-C9C1542D-E9CA-46C0-810E-A4E863EBC638Q53189212-0988D423-6203-4EA2-9074-E9E66571AD98Q54606036-F3C9D97C-6CA3-4277-A7CC-518F142A7796Q57357376-4C24EC36-288F-4611-900C-F1E6606B4BA8Q57369268-14941D80-40F5-4778-8100-7331938E2195Q79996255-ADB10451-33D8-4078-80FA-7FA80AA4D9F7Q81513734-4C400CD3-8B32-44B7-9681-18A5146FD1D1Q84823452-AD435E4B-6780-44C3-90E4-003936C797F5Q87009895-46226C58-9110-46FC-A7CB-9F59193E37A7
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cristina Tringali
@ast
Cristina Tringali
@en
Cristina Tringali
@es
Cristina Tringali
@nl
Cristina Tringali
@sl
type
label
Cristina Tringali
@ast
Cristina Tringali
@en
Cristina Tringali
@es
Cristina Tringali
@nl
Cristina Tringali
@sl
prefLabel
Cristina Tringali
@ast
Cristina Tringali
@en
Cristina Tringali
@es
Cristina Tringali
@nl
Cristina Tringali
@sl
P1053
Q-7259-2017
P106
P1153
7004749042
P21
P31
P3829
P496
0000-0002-0632-6197